Literature DB >> 7176460

Low molecular solutes and the blood cerebrospinal fluid barrier.

K Felgenhauer, N Liappis, M Nekic.   

Abstract

An attempt is made to evaluate those portions of low molecular hydrophilic solutes that obey apparent passive transfer principles at the blood cerebrospinal fluid (CSF) barrier under steady state conditions. Twenty-four electrolytes, metabolites, and amino acids are determined in serum and CSF obtained simultaneously. The correlation found between the serum/CSF concentration ratios and the molecular radii of most compounds is indicative of the prevalence of passive transfer processes in CSF formation, as has been already demonstrated for proteins. The level of some constituents in the primary filtrate may be secondarily increased by influx from the adjacent extracellular space, e.g. glutamine and creatinine, or decreased by specific uptake from the CSF compartment, e.g. glycine. The CSF levels of all compounds are dependent upon the actual state of the blood CSF barrier as evaluated by the serum/CSF concentration ratios of albumin and alpha 2-macroglobulin. The results do not support the assumption that CSF may be used to test the permeability state of the blood brain barrier propery.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7176460     DOI: 10.1007/bf01716243

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  21 in total

1.  Ionic selectivity of Na and K channels of nerve membranes.

Authors:  B Hille
Journal:  Membranes       Date:  1975

2.  Filtration, diffusion, and molecular sieving through porous cellulose membranes.

Authors:  E M RENKIN
Journal:  J Gen Physiol       Date:  1954-11-20       Impact factor: 4.086

3.  Studies of the inter-relationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals.

Authors:  E H McGale; I F Pye; C Stonier; E C Hutchinson; G M Aber
Journal:  J Neurochem       Date:  1977-08       Impact factor: 5.372

4.  The development of a blood-brain barrier mechanism in foetal sheep.

Authors:  C A Evans; J M Reynolds; M L Reynolds; N R Saunders; M B Segal
Journal:  J Physiol       Date:  1974-04       Impact factor: 5.182

5.  Facilitated transport of amino acids through the blood-brain barrier of the dog studied in a single capillary circulation.

Authors:  D L Yudilevich; N De Rose; F V Sepúlveda
Journal:  Brain Res       Date:  1972-09-29       Impact factor: 3.252

6.  Protein size and cerebrospinal fluid composition.

Authors:  K Felgenhauer
Journal:  Klin Wochenschr       Date:  1974-12-15

7.  Measurements of serum urea nitrogen by conductivimetric urease assay.

Authors:  E Horak; F W Sunderman
Journal:  Ann Clin Lab Sci       Date:  1972 Nov-Dec       Impact factor: 1.256

8.  Determination of glucose by an automatic analyser.

Authors:  J F Stevens
Journal:  Clin Chim Acta       Date:  1971-04       Impact factor: 3.786

9.  Serum-CSF protein gradients, the blood-GSF barrier and the local immune response.

Authors:  G Schliep; K Felgenhauer
Journal:  J Neurol       Date:  1978-05-18       Impact factor: 4.849

10.  The distribution within the brain of ferritin injected into cerebrospinal fluid compartments. II. Parenchymal distribution.

Authors:  M W Brightman
Journal:  Am J Anat       Date:  1965-09
View more
  3 in total

1.  Cerebrospinal fluid homocysteine and the cobalamin status of the brain.

Authors:  H J Blom; R A Wevers; A Verrips; M T TePoele-Pothoff; J M Trijbels
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

2.  Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children.

Authors:  Svenja Kristin Kunert; Hans Hartmann; Dieter Haffner; Maren Leifheit-Nestler
Journal:  J Bone Miner Metab       Date:  2016-03-26       Impact factor: 2.626

3.  Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection.

Authors:  J R Bogner; B Junge-Hülsing; U Kronawitter; I Sadri; A Matuschke; F D Goebel
Journal:  Clin Investig       Date:  1992-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.